In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods

Diagnostic Microbiology and Infectious Disease

Volumn 36, Issue 2, 2000, Pages 101-105

  Lewis, Russell E ^a   Klepser, Michael E ^a   Pfaller, Michael A ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCYTOSINE; FUNGUS ISOLATE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FUNGICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; TECHNIQUE; TIME;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; CRYPTOCOCCUS; FLUCYTOSINE; MICROBIAL SENSITIVITY TESTS;

EID: 0033982424     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00125-X     Document Type: Article

References (16)

1. Andes, D. A. & Van Ogtrop, M. L. (1998). In vivo pharmacodynamic characterization of flucytosine in a neutropenic disseminated candidiasis model (Abstr 121:38). Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy.
2. Atkinson B.A., Bouthet C., Bocanegra R., Correa A., Luther M.F., Graybill J.R. Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice. J Antimicrob Chemother. 35:1995;631-640.
3. Bennett J.E., Dismukes W.E., Duma R.J., Medoff G., Sande M.A., Gallis H., Leonard J., Fields B.T., Bradshaw M., Haywood H., McGee Z.A., Cate T.R., Cobbs C.G., Warner J.F., Alling D.W. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med. 301:1979;126-131.
4. Craig W.A. Pharmacokinetic/pharmacodynamic parameters rationale for antibacterial dosing of mice and men . Clin Infect Dis. 26:1998;1-10.
5. Cutler R.E., Blair A.D., Kelly M.R. Flucytosine kinetics in subjects with normal and impaired renal function. Clin Pharmacol Ther. 24:1978;333-342.
6. Francis P., Walsh T.J. Evolving role of flucytosine in immunocompromised patients new insights into safety, pharmacokinetics, and antifungal therapy . Clin Infect Dis. 15:1992;1003-1018.
7. Graybill J.R., Najvar L.K., Holmberg J.D., Luther M.F. Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice. Antimicrob Agents Chemother. 39:1995;924-929.
8. Harder E.J., Hermans P.E. Treatment of fungal infections with flucytosine. Arch Intern Med. 135:1975;231-237.
9. Karyotakis N.C., Anaissie E.J. Efficacy of continuous flucytosine infusion against Candida lusitaniae in experimental hematogenous murine candidiasis. Antimicrob Agents Chemother. 40:1996;2907-2908.
10. Klepser M.E., Ernst E.J., Lewis R.E., Ernst M.E., Pfaller M.A. Influence of test conditions on antifungal time-kill curve results proposal for standardized methods . Antimicrob Agents Chemother. 42:1998;1207-1212.
11. Lewis R.E., Klepser M.E., Pfaller M.E. Combination systemic antifungal therapy for cryptococcosis, candidiasis, and aspergillosis. J Infect Dis Pharm. 3:1999;61-83.
12. Meyer R., Axelrod J.L. Fatal aplastic anemia resulting from flucytosine. JAMA. 228:1974;1573.
13. Polak A. Combination therapy for systemic mycosis. Infection. 17:1989;203-209.
14. National Committee for Clinical Laboratory Standards (NCCLS). (1997). Reference method for broth dilution antifungal susceptibility testing of yeasts: M-27. Villanova, PA: NCCLS.
15. Turnidge J.D., Gudmundsson S., Vogelman B., Craig W.A. The postantibiotic effect of antifungal agents against common pathogenic yeasts. J Antimicrob Chemother. 34:1994;83-92.
16. van der Horst C.M., Saag M.S., Cloud G.A., Hamill R.J., Graybill J.R., Sobel J.D., Johnson P.C., Tuazon C.U., Kerkering T., Moskovitz B.L., Powderly W.G., Dismukes W.E. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med. 337:1997;15-21.